Regarding weight loss, the SURMOUNT-1 trial revealed meaningful results, with participants achieving body weight reductions of up to 20.9% when treated with 15 mg doses over 72 weeks [46]
Complete information on authors, methodology and conflicts of interest is available in the published paper
It works through its GLP-1 effects to decrease glucose
If you've taken other oral GLP-1 medications, you know that they usually come with instructions on timing, fasting, and hydration
Eligible articles contained key words such as veterans, military, low back pain, spine, degenerative spine, spinal fusion, spine surgery, and obesity
In addition, a 2024 study found that people taking another GLP-1 drug, liraglutide, had a 179% higher risk of developing NAION